Skip to content

Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1

Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05560438
Acronym
Technorehab
Enrollment
6
Registered
2022-09-29
Start date
2022-01-03
Completion date
2023-12-31
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myotonic Dystrophy Type 1 (DM1)

Brief summary

Myotonic Dystrophy type 1 (DM1) is a genetic multisystem disease causing muscle weakness and myotonia. As a result, upper limb function might become impaired. There are little research regarding rehabilitation and exercise for upper limb function in DM1. It is known from research on lower limb function in DM1 and other muscular dystrophies, that there are possibilities to improve function also in these deteriorating diseases. In this single subject experimental design study, 6-10 adults with DM1, who are at an inpatient rehabilitation center, will get intensive, but personally adapted senso- and robot assisted rehabilitation for arm- and hand function with Tyromotion Amadeo and Armeo Senso. These devices have previously been used in rehabilitation research for other neurological conditions. The participants will be followed up, and evaluated at a weekly basis, using video consultations. Fine motor skill dexterity test (9HPT) and the Nut and Bolt test will be used, and active range of motion (ROM) and muscle strenght and movement of upper limb will be measured. Furthermore, patient reported outcome measures (PROMS) on hand impairment and myotonia will be used, all with purpose to evaluate upper limb function.

Interventions

DEVICETyromotion Amadeo and Armeo Senso

Robot assisted rehabilitation for arm- and hand function with Tyromotion Amadeo and Armeo Senso

Sponsors

Oslo University Hospital
CollaboratorOTHER
Vikersund Rehabilitation Center
CollaboratorUNKNOWN
University of Oslo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single subject experimental design (SSED) study

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Granted rehabilitation at Vikersund Rehabilitation center Genetical confirmed myotonic dystrophy diagnosis MIRS score between 2-5

Exclusion criteria

* MIRS score on 1 Reduced Cognitive function and unable to participate in technological rehabilitation and digital evaluation

Design outcomes

Primary

MeasureTime frameDescription
Fine motor skill dexterity test, 9 hole peg test (9HPT)1-3 minutesMotor skill test

Secondary

MeasureTime frameDescription
Range of motion (ROM)5-10 minutesMeasure of ROM in upper limb joints
Nut and Bolt test5 minutesMotor skill test
Hand strength5 minutesMeasured by Jamar digital dynamometer
Pinch Gauge5 minutesFinger strength measures by Jamar digital pinch gauge

Other

MeasureTime frameDescription
Abilhand5 minutesPatient reported outcome measure, measure of manual ability for adults with upper limb impairment
Myotonia behavior scale1-5 minutesPatient reported outcome measure

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026